Tamar Securities LLC Purchases 9,522 Shares of SPDR S&P Biotech ETF $XBI

Tamar Securities LLC raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 82,493 shares of the exchange traded fund’s stock after purchasing an additional 9,522 shares during the period. Tamar Securities LLC owned 0.12% of SPDR S&P Biotech ETF worth $13,008,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. United Advisor Group LLC acquired a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at $289,000. International Assets Investment Management LLC grew its holdings in shares of SPDR S&P Biotech ETF by 16.6% during the third quarter. International Assets Investment Management LLC now owns 1,794 shares of the exchange traded fund’s stock worth $277,000 after buying an additional 255 shares in the last quarter. Waldron Private Wealth LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at about $237,000. Sharper & Granite LLC raised its position in shares of SPDR S&P Biotech ETF by 8.3% in the third quarter. Sharper & Granite LLC now owns 6,789 shares of the exchange traded fund’s stock valued at $1,070,000 after buying an additional 523 shares during the last quarter. Finally, Pekin Hardy Strauss Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 52.2% in the third quarter. Pekin Hardy Strauss Inc. now owns 10,804 shares of the exchange traded fund’s stock worth $1,704,000 after buying an additional 3,704 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI traded up $3.81 during trading hours on Friday, reaching $152.21. The company’s stock had a trading volume of 10,549,785 shares, compared to its average volume of 9,198,628. SPDR S&P Biotech ETF has a fifty-two week low of $106.30 and a fifty-two week high of $169.89. The business’s 50-day moving average is $155.22 and its 200-day moving average is $142.29. The stock has a market cap of $10.41 billion, a PE ratio of 11.47 and a beta of 0.87.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.